Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

By HEATHER MURPHY from NYT Health https://nyti.ms/2GlsXBT
via IFTTT
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns - By HEATHER MURPHY - at Health - Keyword: Genetics and Heredity, Tests (Medical), Breast Cancer, Ovarian Cancer - From The New York Times - Published at April 16, 2019 at 07:00AM